“Ruxolitinib Cream Is Associated With Reduced Treatment Burden in Atopic Dermatitis: A US Payer Claim Analysis”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 6, Nov. 2025, p. s591, https://doi.org/10.25251/9yfem502.